Dunlop A. Sinclair Insider Trades

Insider Trading History

Track insider trading activity for Dunlop A. Sinclair. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$6.63M 161,567 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.28M 106,370 shares
$40.26
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $6.63M 161,567 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$569k 22,645 shares
$25.12
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
Oct 10, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$96.4k 3,837 shares
$25.12
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $157k 3,837 shares
Last Trade
Oct 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$738k 31,092 shares
$23.72
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.39M 33,979 shares
Last Trade
Sep 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$702k 31,092 shares
$22.58
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.24M 30,142 shares
Last Trade
Sep 30, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$86.8k 3,837 shares
$22.63
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $2.67M 65,071 shares
Last Trade
Sep 19, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$88.3k 3,837 shares
$23.01
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $2.83M 68,908 shares
Last Trade
Sep 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$714k 31,092 shares
$22.95
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $6.3M 153,606 shares
Last Trade
Jun 24, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$89.1k 4,787 shares
$18.61
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $6.5M 158,393 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$357k 11,199 shares
$31.91
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
Sep 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$151k 4,600 shares
$32.72
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $6.24M 152,126 shares
Last Trade
Sep 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$151k 4,600 shares
$32.72
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $4.41M 107,524 shares
Last Trade
Sep 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.34M 37,000 shares
$36.23
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $5.52M 134,418 shares
Last Trade
Jun 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.5k 900 shares
$38.36
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $189k 4,600 shares
Last Trade
Jun 28, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.5k 900 shares
$38.36
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $5.69M 138,693 shares
Last Trade
Jun 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.45M 37,000 shares
$39.24
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $226k 5,500 shares
Last Trade
Apr 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$77.7k 1,500 shares
$51.79
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $5.48M 133,518 shares
Last Trade
Apr 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$77.7k 1,500 shares
$51.79
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $7.14M 173,998 shares
Last Trade
Mar 19, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.07M 18,681 shares
$57.18
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up